Diabetes Peptides
Peptides used in the treatment and management of type 2 diabetes, including GLP-1 receptor agonists and dual/triple agonists that improve blood sugar control and reduce cardiovascular risk.
All Diabetes Peptides (3)
Semaglutide
FDA ApprovedGLP-1 Receptor Agonists
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes management and chronic weight management. It mimics the nat...
Type 2 diabetesChronic weight managementCardiovascular risk reduction
Tirzepatide
FDA ApprovedGLP-1 Receptor Agonists
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. It produces the most signi...
Type 2 diabetesChronic weight managementObstructive sleep apnea
Liraglutide
FDA ApprovedGLP-1 Receptor Agonists
Liraglutide is a GLP-1 receptor agonist with 97% structural similarity to human GLP-1. It was one of the first long-acting GLP-1 drugs, paving the way...
Type 2 diabetesWeight management
Comparison Table
| Peptide | Legal Status (USA) | Evidence | Administration | Half-Life | Primary Uses |
|---|---|---|---|---|---|
| Semaglutide | FDA Approved | A | subcutaneous, oral | ~7 days (injectable) | Type 2 diabetesChronic weight management+1 |
| Tirzepatide | FDA Approved | A | subcutaneous | ~5 days | Type 2 diabetesChronic weight management+1 |
| Liraglutide | FDA Approved | A | subcutaneous | ~13 hours | Type 2 diabetesWeight management |